Registry of Lobbyists
Total Number of Communication Reports: 60
Monthly communication reports in the last 6 months: 0
End date of the last completed financial year: 2011-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Defense Advanced Research Projects Agency (DARPA) | $9,400,000.00 | No |
| Quebec Consortium for Drug Discovery | $338,000.00 | No |
Address:
1020 route de l'Eglise
bureau 600
Quebec City, QC G1V 3V9
Canada
Telephone number:
418-658-9393
Ext.
141
Web address:
www.medicago.com
Frederic Ors, Vice President, Business Development
Medicago Inc / Medicago Inc is not a subsidiary of any other parent companies.
Medicago Inc / Medicago Inc is not a coalition.
The activities of Medicago Inc / Medicago Inc are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Medicago Inc / Medicago Inc does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Danielle Peters | No public offices held
Firm: The Rothwell Group
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
| Name | From | To |
|---|---|---|
| Medicago Inc/Medicago Inc | 2013-01-30 | 2023-04-01 |
| Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
|---|
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.